| Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732) |
|---|
| 08/17/2010 | CA2427227C Lactam compound |
| 08/17/2010 | CA2425497C (n)-((s)-2-hydroxy-3-methyl-butyryl-1-(l-alaninyl)-(s)-1-amino-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepin-2-one dihydrate and its use in the treatment of alzheimer's disease |
| 08/12/2010 | WO2010089475A1 Novel method for the synthesis of ivabradine and the pharmaceutically acceptable acid addition salts thereof |
| 08/12/2010 | CA2750089A1 Novel method for the synthesis of ivabradine and the pharmaceutically acceptable acid addition salts thereof |
| 08/11/2010 | EP1487763B1 Use of microfabricated devices for radiosynthesis |
| 08/11/2010 | CN1827600B Crystalline form beta of the chlorhydrate of ivabradine, process for its preparation and pharamcetuical composition containing it |
| 08/11/2010 | CN101801377A Anti-inflammatory composition |
| 08/10/2010 | US7772432 amidation of a heteroary substituted oxoaminobenzoic acid with an amine; for treatment of psoriasis and rheumatoid arthritis using e.g. N-(3-dimethylaminophenyl)-3-(3-methoxybenzamido)-4-methylbenzamide |
| 08/10/2010 | US7772247 vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) receptor antagonists such as 1-(4-(2-(N-methoxy-N-methylcarbamoyl)thieno[3,2-b]pyridin-7yloxy)-3-fluorophenyl)-3-(2-phenylacetyl)thiourea, used as antiproliferative agents |
| 08/10/2010 | US7772225 N-sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions |
| 08/05/2010 | US20100197664 Novel b1-antagonists |
| 08/05/2010 | US20100197660 Azepine derivatives as gamma-secretase inhibitors |
| 08/04/2010 | EP2212293A1 Heterocycle amide t-type calcium channel antagonists |
| 08/04/2010 | CN101792417A Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases |
| 07/29/2010 | US20100191475 Method for identification and functional characterization of agents which modulate ion channel activity |
| 07/29/2010 | US20100190753 Methods and Compositions for Treating Amyloid-Related Diseases |
| 07/29/2010 | US20100190688 Tetrapeptide analogs |
| 07/28/2010 | CN101786987A Extraction equipment of caprolactam |
| 07/28/2010 | CN101786986A (+)-meptazinol prodrug or salt thereof and preparation method thereof |
| 07/28/2010 | CN101786010A Catalyst for preparing caprolactam by gas phase Beckmann rearrangement method and preparation method thereof |
| 07/22/2010 | WO2010081342A1 Methods for the preparation of ivabradine sulfate and form i crystal thereof |
| 07/22/2010 | WO2010041943A3 METHOD FOR PREPARING ε-CAPROLACTAM FROM N-ACYL-6-AMINOCAPROIC ACID |
| 07/22/2010 | US20100184741 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 07/21/2010 | CN101784524A Ionic liquids |
| 07/21/2010 | CN101781249A Synthesis method of 10-oxa-10,11-dihydro-5H-dibenzo(b,f) azepine |
| 07/21/2010 | CN101781248A Method for synthesizing N-methylhexahydroazepin-4-one hydrochloride, azelastine hydrochloride intermediate |
| 07/20/2010 | US7759388 Phenylalanine derivatives |
| 07/20/2010 | US7759336 chemokine receptor antagonists such as N-(4-azepan-1-ylpyrimidin-2-yl)ethane-1,2-diamine, used for the treatment and prevention of inflammatory diseases, allergic diseases, acquired immunodeficiency syndrome infection with human immunodeficiency virus |
| 07/20/2010 | CA2431982C Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 07/15/2010 | WO2010079324A1 Ammoximation process |
| 07/15/2010 | US20100179317 Ammoximation process |
| 07/15/2010 | US20100179316 Process for the preparation of ivabradine hydrochloride and polymorph thereof |
| 07/14/2010 | CN101778826A Azepine derivatives as gamma-secretase inhibitors |
| 07/14/2010 | CN101774969A Ivabradine sulfate and method for preparing type I crystal thereof |
| 07/13/2010 | US7754750 a -5 substituted 1-H,3-H-imidazolidine-2,4-dione such as 5-(2-{[4-(4'-fluoro[1,1'-biphenyl]-4-yl)-1-piperazinyl]sulfonyl}ethyl)-2,4-imidazolidinedione; protease inhibitors, especially metalloelastase (MMP12) |
| 07/13/2010 | US7754709 Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds |
| 07/13/2010 | CA2567776C Vasopressin v1a antagonists |
| 07/08/2010 | US20100173894 Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
| 07/08/2010 | US20100173893 Preparation of eslicarbazepine and related compounds by asymmetric hydrogenation |
| 07/08/2010 | US20100173890 Compounds, Process for their Preparation, Intermediates, Pharmaceutical Compositions and their use in the Treatment of 5-HT6 Mediated Disorders such as Alzheimer's Disease, Cognitive Disorders, Cognitive Impairment Associated with Schizophrenia, Obesity and Parkinson's Disease |
| 07/08/2010 | US20100173880 Alkaloid aminoester derivatives and medicinal composition thereof |
| 07/08/2010 | US20100173824 Azepinoindole Derivatives As Pharmaceutical Agents |
| 07/07/2010 | EP1940817B1 Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
| 07/07/2010 | CN101768176A Ionic liquid |
| 07/07/2010 | CN101768117A New crystalline form of hydrochloric acid Ivabradine and preparation method thereof |
| 07/07/2010 | CN101768116A Preparation method for Ivabradine |
| 07/07/2010 | CN101768100A N-(4-nitrophenylmethyl) lactam compound and preparation method thereof |
| 07/07/2010 | CN101767860A Recovery process of caprolactam refining raffinate |
| 07/06/2010 | US7749993 Utillizing vasopressin antagonistic agent such as 5-dimethylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine; safe with few side effects |
| 07/06/2010 | US7749992 modulators of Cholesterol ester transfer protein activity, such as 5-[Acetyl-(3,5-bis-trifluoromethyl-benzyl)-amino]-7-trifluoromethyl-2,3,4,5-tetrahydro-benzo[b]azepine-1-carboxylic acid isopropyl ester, for treating or preventing cardiovascular disorders |
| 07/01/2010 | WO2010072930A1 Novel method for the synthesis of ivabradine |
| 07/01/2010 | WO2010072409A1 Process for preparation of ivabradine |
| 07/01/2010 | WO2010011924A3 Monomers derived from alpha-or beta-amino-e-caprolactam and polymers made therefrom |
| 07/01/2010 | US20100168083 Adamantane derivatives for the treatment of the metabolic syndrome |
| 06/30/2010 | EP2202225A1 New method for synthesising ivabradine and its added salts with a pharmaceutically acceptable acid. |
| 06/30/2010 | EP1735270B1 Diamino alcohols and their use as renin inhibitors |
| 06/30/2010 | CN101759643A New method for synthesising ivabradine and its added salts with a pharmaceutically acceptable acid. |
| 06/24/2010 | US20100160628 Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid |
| 06/24/2010 | US20100160627 (2,3-cis)-3-amino-2-phenyl-2,3-dihydro-1,5-benzoxazepin-4(5H)-one; for treatment of neurological disorders related to amyloid beta protein production such as Alzheimer's disease; inhibit gamma secretase and thereby inhibit the production of amyloid beta protein |
| 06/24/2010 | US20100160296 Use of imipramine blue and analogs thereof in treating cancers |
| 06/24/2010 | US20100160293 Solid Ophthalmic Drug for External Use |
| 06/24/2010 | US20100159596 Small molecule compounds for stem cell differentiation |
| 06/24/2010 | US20100158818 Antimicrobial n-chlorinated compositions |
| 06/23/2010 | CN1875004B Resolution of a narwedine amide derivative |
| 06/23/2010 | CN101747324A Sulfonamide derivatives |
| 06/23/2010 | CN101747248A Method for preparation of hexanolactam with 5-formoxyl methyl valerate |
| 06/23/2010 | CN101307021B Chemical synthesis process for iminostilbene |
| 06/22/2010 | US7741317 LXR modulators |
| 06/17/2010 | US20100152165 Carboxylic acid derivatives |
| 06/17/2010 | US20100152125 Compositions And Methods For The Diagnosis, Treatment, And Prevention Of Amyotrophic Lateral Sclerosis And Related Neurological Diseases |
| 06/16/2010 | CN1805938B Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases |
| 06/15/2010 | US7737142 (Thio) carbamoyl-cyclohexane derivatives as D3/D2 receptor antagonists |
| 06/15/2010 | CA2564369C Delta crystalline form of ivabradine chlorhydrate, process for its preparation and pharmaceutical compositions containing it |
| 06/10/2010 | WO2010064871A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 06/10/2010 | US20100145040 Benzazepine Derivatives For The Treatment of Neurological Disorders |
| 06/10/2010 | US20100145003 Catalytic Deamination for Caprolactam Production |
| 06/09/2010 | EP2194139A1 Biochemical synthesis of 6 amino caproic acid |
| 06/09/2010 | CN101723897A Method for synthesizing Ivabradine |
| 06/03/2010 | WO2010062107A1 Organic electroluminscent device using electroluminescent compounds |
| 06/03/2010 | US20100137582 N-pyridylpiperidine compound, method for producing the same, and pest control agent |
| 06/02/2010 | EP2190820A2 Substituted azepine- and diazepine-sulfonamides useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1 |
| 06/02/2010 | CN1926240B Biochemical synthesis of 6-amino caproic acid |
| 06/01/2010 | US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/27/2010 | US20100130477 Spirocyclobutyl Piperidine Derivatives |
| 05/27/2010 | US20100129473 AMINO SUBSTITUTED DIARYL[a,d]CYCLOHEPTENE ANALOGS AS MUSCARINIC AGONISTS AND METHODS OF TREATMENT OF NEUROPSYCHIATRIC DISORDERS |
| 05/26/2010 | EP2189448A1 Processes for the Separation of 3-Benzazepine Racemates |
| 05/26/2010 | EP1315709B1 Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 05/26/2010 | CN1953963B Process for producing cyclic N-hydroxyimide compound |
| 05/26/2010 | CN101712650A Method for synthesizing caprolactam in one step by liquid phase hydrogenation of nitrocyclohexane |
| 05/26/2010 | CN101168524B Method for preparing low sulfonated caprolactam |
| 05/25/2010 | US7723514 Method of preparing a 5H-dibenz(b,f)azepine-5-carboxamide |
| 05/25/2010 | US7723384 1H-2-Benzazepine-1,5(2H)-dione derivatives in which the N is connected via alkylene to a saturated or monounsaterated nitrogen heterocycle, e.g.,2-(3-{4-[2-tert-Butyl-6-(trifluoromethyl)pyrimidin-4-yl]piperazin-1-yl}propyl)-3,4-dihydro-1H-2-benzazepine-1,5(2H)-dione; dopamine-3 receptor modulators |
| 05/25/2010 | CA2496723C New process for synthesizing ivrabradine and its pharmaceutically acceptable acid addition salts |
| 05/25/2010 | CA2362273C Benzazepine-n-ethanoic acid derivatives for treating secondary hypertension |
| 05/19/2010 | EP2186516A1 Novel benzazepine derivative |
| 05/19/2010 | EP2185151A1 Anti-inflammatory composition |
| 05/19/2010 | CN101709053A Process for preparing caprolactam |
| 05/18/2010 | US7718795 Succinoylamino benzodiazepines as inhibitors of aβ protein production |
| 05/18/2010 | US7718675 Diamino alcohols and their use as renin inhibitor |
| 05/18/2010 | US7718658 Saturated ring with 2 nitrogens, 1 of which is 2-(o-(difluoromethyl)phenyl)quinazol-4-yl-substituted and the other is oxyalkanoyl-substituted; inhibitors of voltage-gated sodium channels and calcium channels; treating acute, chronic, neuropathic, or inflammatory pain |